BreathSpec® features at ADTCA 2021

#ADTCA2021 saw more than 75 delegates from 23 countries gather online on 24 June 2021 to discuss how data tech can be used to prevent, detect and diagnose infectious disease, enable antimicrobial stewardship and underpin effective antimicrobial therapeutics. 

We were delighted to be able to join this meeting and to share some of our experiences of carrying out a clinical study to test the feasibility of using BreathSpec® to differentiate between bacterial and viral causes of respiratory tract infections in primary and secondary care. We look forward to being able to continue this conversation as the discussion is carried forward.